应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
盘前交易 07-30 07:29:50 EDT
53.94
-15.06
-21.83%
盘前
52.08
-1.86
-3.44%
07:29 EDT
最高
55.37
最低
53.51
成交量
1.11亿
今开
53.95
昨收
69.00
日振幅
2.70%
总市值
2,394亿
流通市值
1,717亿
总股本
44.39亿
成交额
60.13亿
换手率
3.48%
流通股本
31.84亿
市净率
11.74
ROE
88.12%
每股收益
3.40
52周最高
139.74
52周最低
53.51
市盈率
15.86
股息
1.60
股息收益率
0.03
ROA
23.29%
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
美国银行下调诺和诺德评级至中性
格隆汇 · 10:10
美国银行下调诺和诺德评级至中性
丹麦制药巨头重大调整
药智网 · 09:33
丹麦制药巨头重大调整
市值蒸发500亿美元背后,诺和诺德的艰难一仗
第一财经 · 08:19
市值蒸发500亿美元背后,诺和诺德的艰难一仗
“减肥神药”神话破灭,诺和诺德是如何跌落王座的?
华尔街见闻 · 06:48
“减肥神药”神话破灭,诺和诺德是如何跌落王座的?
特朗普拟对进口药品征收高额关税,谁最可能受影响?
智通财经网 · 05:40
特朗普拟对进口药品征收高额关税,谁最可能受影响?
诺和诺德7月29日成交额为60.23亿美元
市场透视 · 04:47
诺和诺德7月29日成交额为60.23亿美元
美股成交额TOP20|诺和诺德重挫近22%,大幅下调业绩指引;联合健康跌超7%,年度利润指引不及预期
新浪财经 · 07-29 21:40
美股成交额TOP20|诺和诺德重挫近22%,大幅下调业绩指引;联合健康跌超7%,年度利润指引不及预期
美股暴跌近22%!诺和诺德减肥药Wegovy销售不及预期,任命新CEO并下调全年指引
华尔街见闻 · 07-29 21:37
美股暴跌近22%!诺和诺德减肥药Wegovy销售不及预期,任命新CEO并下调全年指引
马齐亚尔·迈克·杜斯特达尔被任命为诺和诺德下一任首席执行官兼总裁Maziar Mike Doustdar Named Next CEO and President of Novo Nordisk
动脉网 · 07-29 14:06
马齐亚尔·迈克·杜斯特达尔被任命为诺和诺德下一任首席执行官兼总裁Maziar Mike Doustdar Named Next CEO and President of Novo Nordisk
美股异动 | 大幅下调全年业绩指引 诺和诺德(NVO.US)大跌超20%
智通财经 · 07-29 13:41
美股异动 | 大幅下调全年业绩指引 诺和诺德(NVO.US)大跌超20%
诺和诺德:100万美国患者使用复方减肥药
DoNews · 07-29 13:33
诺和诺德:100万美国患者使用复方减肥药
诺和诺德CFO:Wegovy在直接面向消费者渠道的渗透率低于预期
格隆汇 · 07-29 12:41
诺和诺德CFO:Wegovy在直接面向消费者渠道的渗透率低于预期
诺和诺德CFO:司美格鲁肽的非法配制仍在继续
格隆汇 · 07-29 12:41
诺和诺德CFO:司美格鲁肽的非法配制仍在继续
诺和诺德新CEO:将采取紧急行动 运营更加高效
格隆汇 · 07-29 12:41
诺和诺德新CEO:将采取紧急行动 运营更加高效
盘前 | 英伟达势创新高,诺和诺德大跌,理想汽车涨逾6%
老虎资讯综合 · 07-29 12:26
盘前 | 英伟达势创新高,诺和诺德大跌,理想汽车涨逾6%
在诺和诺德发布盈利预警后,欧洲斯托克600指数回吐涨幅,最新上涨0.3%。
金融界 · 07-29 11:57
在诺和诺德发布盈利预警后,欧洲斯托克600指数回吐涨幅,最新上涨0.3%。
诺和诺德股价一度大跌17% 此前下调全年展望
环球市场播报 · 07-29 11:44
诺和诺德股价一度大跌17% 此前下调全年展望
Mike Doustdar被任命为诺和诺德CEO
格隆汇 · 07-29 11:41
Mike Doustdar被任命为诺和诺德CEO
美股前瞻 | 三大股指期货齐涨,诺和诺德下调2025年展望
智通财经 · 07-29 11:40
美股前瞻 | 三大股指期货齐涨,诺和诺德下调2025年展望
诺和诺德:前六个月,诺和诺德的销售额增长了18%
金融界 · 07-29 11:23
诺和诺德:前六个月,诺和诺德的销售额增长了18%
加载更多
公司概况
公司名称:
诺和诺德
所属市场:
NYSE
上市日期:
1981-07-09
主营业务:
Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球医疗保健公司,也是糖尿病和肥胖症护理领域的全球领导者。该公司拥有广泛的糖尿病和肥胖症护理以及罕见疾病产品组合,包括用于治疗糖尿病和肥胖症的胰高血糖素样肽-1(GLP-1)受体激动剂、现代胰岛素和人胰岛素。
发行价格:
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":53.94,"timestamp":1753819200000,"preClose":69,"halted":0,"volume":110735641,"hourTrading":{"tag":"盘前","latestPrice":52.08,"preClose":53.937,"latestTime":"07:29 EDT","volume":956771,"amount":49903258.947687,"timestamp":1753874985795},"delay":0,"floatShares":3183545765,"shares":4439052849,"eps":3.401716,"marketStatus":"盘前交易","change":-15.06,"latestTime":"07-30 07:29:49 EDT","open":53.95,"high":55.37,"low":53.51,"amount":6012990043.498964,"amplitude":0.026957,"askPrice":52.08,"askSize":419,"bidPrice":52.07,"bidSize":10,"shortable":0,"etf":0,"ttmEps":3.401716,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753882200000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":53.937,"dividendRate":0.029663,"preHourTrading":{"tag":"盘前","latestPrice":52.08,"preClose":53.937,"latestTime":"07:29 EDT","volume":956771,"amount":49903258.947687,"timestamp":1753874985795},"postHourTrading":{"tag":"盘后","latestPrice":54.39,"preClose":53.94,"latestTime":"19:59 EDT","volume":702198,"amount":38204493.4706,"timestamp":1753833598054},"volumeRatio":12.137256777106472,"optionData":{"bulkOrders":[{"symbol":"NVO","call":false,"expireDate":1758254400000,"strike":"45.0","timestamp":1753796350430,"price":0.68,"volume":16148,"amount":1098064,"type":"-"},{"symbol":"NVO","call":false,"expireDate":1773979200000,"strike":"50.0","timestamp":1753810640838,"price":4.7,"volume":4000,"amount":1880000,"type":"+"}]},"impliedVol":0.5414,"impliedVolPercentile":0.8193},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"2555017917","title":"美国银行下调诺和诺德评级至中性","url":"https://stock-news.laohu8.com/highlight/detail?id=2555017917","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555017917?lang=zh_cn&edition=full","pubTime":"2025-07-30 18:10","pubTimestamp":1753870210,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","LU0130103400.USD","LU0787776722.HKD","LU0980610538.SGD","BK4534","LU0106831901.USD","LU1201861249.SGD","IE00B7SZLL34.SGD","LU1894683348.USD","LU1894683264.USD","LU0640476718.USD","LU0053666078.USD","LU0477156797.USD","LU0149725797.USD","LU0683600562.USD","LU0971096721.USD","LU2133065610.SGD","LU1496350171.SGD","LU0868494617.USD","LU0256863811.USD","BK4207","LU1093756168.USD","BK4532","LU1718418525.SGD","BK4599","LU0130517989.USD","LU1366192091.USD","IE00BFXG1179.USD","LU0321505868.SGD","LU0234572021.USD","LU2129689431.USD","LU0130518102.USD","IE0002270589.USD","LU1280957306.USD","LU0648001328.SGD","LU1069347547.HKD","BK4559","LU1496350502.SGD","IE00BLSP4452.SGD","BK4581","LU1883839398.USD","NVO","BAC","LU1267930227.SGD","LU0154236417.USD","LU0320765646.SGD","LU0310800965.SGD","LU1791807156.HKD","LU0321505439.SGD","LU0170899867.USD"],"gpt_icon":0},{"id":"2555178960","title":"丹麦制药巨头重大调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2555178960","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555178960?lang=zh_cn&edition=full","pubTime":"2025-07-30 17:33","pubTimestamp":1753867988,"startTime":"0","endTime":"0","summary":"公司正通过诉讼等多项策略保护患者免受仿冒“司美格鲁肽”药物危害,并呼吁联邦及州监管机构加强执法。不过,CVS全国模板处方集变更已于2025年7月1日生效,使Wegovy成为唯一纳入肥胖症覆盖的GLP-1药物,预计将产生积极影响。一方面受到礼来替尔泊肽等同类创新药的强势追击,另一方面受到非法仿制药的市场挤压,销售额增速并未如预期般高歌猛进。7月29日,诺和诺德宣布任命Maziar Mike Doustdar为总裁兼首席执行官,该任命自2025年8月7日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730174656a6c97cf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730174656a6c97cf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4599","BK4585","NVO","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","BK4007"],"gpt_icon":1},{"id":"2555101953","title":"市值蒸发500亿美元背后,诺和诺德的艰难一仗","url":"https://stock-news.laohu8.com/highlight/detail?id=2555101953","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555101953?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:19","pubTimestamp":1753863540,"startTime":"0","endTime":"0","summary":"消息公布后,诺和诺德股价一度暴跌近30%,截至收盘,股价下跌约22%,市值一夜蒸发超过500亿美元。今年以来,诺和诺德股价累计下跌已超过44%,目前市值仅为去年峰值时期的一半左右。尽管该公司研发的司美格鲁肽为全球首款创新机制的GLP-1类减重药,但在美国制药巨头礼来的减重药获批后,诺和诺德的市场份额受到挤压。在中国,诺和诺德近期内还将面临核心药物司美格鲁肽分子专利到期的压力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730163147a46b3362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730163147a46b3362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4599","BK4585","NVO","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","BK4007"],"gpt_icon":1},{"id":"2555709090","title":"“减肥神药”神话破灭,诺和诺德是如何跌落王座的?","url":"https://stock-news.laohu8.com/highlight/detail?id=2555709090","media":"华尔街见闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555709090?lang=zh_cn&edition=full","pubTime":"2025-07-30 14:48","pubTimestamp":1753858125,"startTime":"0","endTime":"0","summary":"从产能失误到营销落后,再到新药试验翻车,诺和诺德在“减肥神药”战场三连失手,失去先发红利,被礼来反超。","market":"sg","thumbnail":"https://community-static.tradeup.com/news/7995b75f7561085f01afe3c6f23b4c86","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7995b75f7561085f01afe3c6f23b4c86"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3752216","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3752216","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LU0154236417.USD","LU1093756168.USD","LU1093756325.SGD","BK4599","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4007","BK4532","BK4585"],"gpt_icon":1},{"id":"2555064777","title":"特朗普拟对进口药品征收高额关税,谁最可能受影响?","url":"https://stock-news.laohu8.com/highlight/detail?id=2555064777","media":"智通财经网","labels":["policyRegulatory"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555064777?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:40","pubTimestamp":1753854000,"startTime":"0","endTime":"0","summary":"7月30日,美国总统特朗普即将对进口药品加征关税,这一政策可能最快于8月1日开始实施,并在未来一年或一年半内逐步提高税率。包括罗氏在内的多家药企高管近期对药品关税提出强烈批评,认为该政策将损害研发投入,并最终导致患者可获得的治疗选择减少。罗氏强调,药品和诊断应被排除在关税之外,以保护患者可及性和未来的医疗创新。但公司也表示,已做好准备应对潜在关税,通过库存调整等方式确保产品供应不受影响。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323364.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"特朗普拟对进口药品征收高额关税,谁最可能受影响?","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["MRK","GILD","ZTS","NVS","BK4551","AZN","BK4535","SNY","AMGN","LLY","NVO","BIIB","GSK","BMY","BK4023","BK4503","RHHBY","PFE","VRTX"],"gpt_icon":1},{"id":"2555094645","title":"诺和诺德7月29日成交额为60.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555094645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555094645?lang=zh_cn&edition=full","pubTime":"2025-07-30 12:47","pubTimestamp":1753850864,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日,诺和诺德成交额为60.23亿美元,成交额较昨日增加1108.42%,当日成交量为1.11亿股。诺和诺德于2025年7月29日跌21.83%,报53.94美元,该股过去5个交易日跌19.23%,年初至今跌36.45%,过去60日跌17.77%。诺和诺德还有一个生物制药部门,专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730124746a6c8fda7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730124746a6c8fda7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4599","BK4585","NVO","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","BK4007"],"gpt_icon":1},{"id":"1134301943","title":"美股成交额TOP20|诺和诺德重挫近22%,大幅下调业绩指引;联合健康跌超7%,年度利润指引不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1134301943","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134301943?lang=zh_cn&edition=full","pubTime":"2025-07-30 05:40","pubTimestamp":1753825212,"startTime":"0","endTime":"0","summary":"据悉,英伟达此次向台积电的新订单,将补充其现有的60万至70万块H20芯片库存。另有消息人士称,英伟达已要求有意购买H20芯片的中国企业提交新文件,包括客户的订单量预测。第4名$联合健康$收跌7.46%,成交111.13亿美元。该公司第二财季营收42亿欧元,低于市场预期。该公司今年第二次下调全年业绩指引。该公司2025年上半年收入同比增长18%,营业利润同比增长29%。上述业绩不及业内预期。美国总统特朗普周二再次抱怨波音推迟交付空军一号专机。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-07-30/doc-infietxh8773654.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"XLCJ","symbols":["UNH","NVO"],"gpt_icon":1},{"id":"2555649710","title":"美股暴跌近22%!诺和诺德减肥药Wegovy销售不及预期,任命新CEO并下调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2555649710","media":"华尔街见闻","labels":["executive","dataReport"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555649710?lang=zh_cn&edition=full","pubTime":"2025-07-30 05:37","pubTimestamp":1753825055,"startTime":"0","endTime":"0","summary":"主要原因是其旗舰减肥药物 Wegovy 在现金支付渠道的销售表现低于预期,受到“不安全且非法的大规模仿制药”冲击。29日周二,丹麦制药巨头诺和诺德在减肥药销售放缓导致利润预警后,提拔国际业务负责人Maziar Mike Doustdar担任新任首席执行官,同时大幅下调全年财务指引。受此影响,诺和诺德股价暴跌高达28%,市值蒸发930亿美元。诺和诺德Wegovy现金渠道销售承压诺和诺德原定于8月6日发布二季度财报,但选择提前发布业绩预警。","market":"us","thumbnail":"https://static.tigerbbs.com/39b1eb5c8ca5e1edf5f0ec76a30e9412","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/39b1eb5c8ca5e1edf5f0ec76a30e9412"],"rights":{"source":"wallstreetcn_api","url":"https://wallstreetcn.com/articles/3752152","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3752152","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"诺和诺德减肥药Wegovy销售不及预期,任命新CEO并下调全年指引","news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_api","symbols":["NVO"],"gpt_icon":1},{"id":"2555057209","title":"马齐亚尔·迈克·杜斯特达尔被任命为诺和诺德下一任首席执行官兼总裁Maziar Mike Doustdar Named Next CEO and President of Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2555057209","media":"动脉网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555057209?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:06","pubTimestamp":1753797960,"startTime":"0","endTime":"0","summary":"by Mark Chiang马克·蒋Share To分享到Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new Chief Executive Officer and President. Doustdar, who currently serves as the company’s head of international operations, will assume his new role following a leadership transition. The decision marks a significant development for the global pharmaceutical company, which is known for its focus on diabetes care and other chronic diseases..诺和诺德宣布任命马齐亚尔·迈克·杜斯塔尔为新任首席执行官兼总裁。The announcement comes as Novo Nordisk continues to expand its presence in international markets under Doustdar’s leadership in his current position. His tenure overseeing international operations has been marked by efforts to strengthen the company’s footprint outside of Denmark, where it is headquartered.该公告发布之际,诺和诺德在道斯特达尔现任职位的领导下,继续扩大其在国际市场的影响力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922093494c1b4de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922093494c1b4de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4599","BK4585","NVO","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","BK4007"],"gpt_icon":1},{"id":"2555054733","title":"美股异动 | 大幅下调全年业绩指引 诺和诺德(NVO.US)大跌超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555054733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555054733?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:41","pubTimestamp":1753796487,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756168.USD","BK4007","BK4532","BK4585","NVO","LU1093756325.SGD","LU0154236417.USD"],"gpt_icon":0},{"id":"2555305445","title":"诺和诺德:100万美国患者使用复方减肥药","url":"https://stock-news.laohu8.com/highlight/detail?id=2555305445","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555305445?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:33","pubTimestamp":1753795983,"startTime":"0","endTime":"0","summary":"2025年7月29日,诺和诺德首席财务官表示,最新市场调研显示,目前有100万美国患者正在使用该公司的复方减肥药。这一数据与此前调研结果一致,表明市场需求稳定。复方减肥药作为诺和诺德的重要产品之一,近年来受到广泛关注。公司将继续监测市场动态,并推进相关产品的研发与推广。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292135329725876f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292135329725876f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","NVO","BK4585","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","BK4007"],"gpt_icon":0},{"id":"2555510300","title":"诺和诺德CFO:Wegovy在直接面向消费者渠道的渗透率低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2555510300","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555510300?lang=zh_cn&edition=full","pubTime":"2025-07-29 20:41","pubTimestamp":1753792914,"startTime":"0","endTime":"0","summary":"格隆汇7月29日|诺和诺德首席财务官:司美格鲁肽的非法配制仍在继续,呼吁美国执法部门采取积极干预措施。Wegovy在直接面向消费者渠道的渗透率低于预期。将继续扩大Wegovy对消费者的直接销售。美国的Wegovy处方出现一些积极进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729204417972570c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729204417972570c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4585","LU1093756325.SGD","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVO","BK4532","LU1093756168.USD","BK4007","LU0154236417.USD"],"gpt_icon":0},{"id":"2555005947","title":"诺和诺德CFO:司美格鲁肽的非法配制仍在继续","url":"https://stock-news.laohu8.com/highlight/detail?id=2555005947","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555005947?lang=zh_cn&edition=full","pubTime":"2025-07-29 20:41","pubTimestamp":1753792914,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","LU0154236417.USD","BK4585","LU1093756168.USD","NVO","BK4532","BK4599","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2555051053","title":"诺和诺德新CEO:将采取紧急行动 运营更加高效","url":"https://stock-news.laohu8.com/highlight/detail?id=2555051053","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555051053?lang=zh_cn&edition=full","pubTime":"2025-07-29 20:41","pubTimestamp":1753792885,"startTime":"0","endTime":"0","summary":"格隆汇7月29日|诺和诺德新CEO杜斯特达尔:诺和诺德将采取紧急行动,更加专注,运营更加高效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292042159725701f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292042159725701f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4588","LU1093756168.USD","LU1093756325.SGD","BK4532","LU0154236417.USD","BK4585"],"gpt_icon":0},{"id":"1103470720","title":"盘前 | 英伟达势创新高,诺和诺德大跌,理想汽车涨逾6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103470720","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103470720?lang=zh_cn&edition=full","pubTime":"2025-07-29 20:26","pubTimestamp":1753792008,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段集体上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LI","NVO","NVDA"],"gpt_icon":0},{"id":"2555405571","title":"在诺和诺德发布盈利预警后,欧洲斯托克600指数回吐涨幅,最新上涨0.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2555405571","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555405571?lang=zh_cn&edition=full","pubTime":"2025-07-29 19:57","pubTimestamp":1753790244,"startTime":"0","endTime":"0","summary":"在诺和诺德发布盈利预警后,欧洲斯托克600指数回吐涨幅,最新上涨0.3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/29195752062396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1093756325.SGD","NVO","IE00BKVL7J92.USD","LU1093756168.USD","BK4588","BK4532","IE00BZ1G4Q59.USD","BK4007","LU0154236417.USD","BK4599","BK4585"],"gpt_icon":0},{"id":"2555405590","title":"诺和诺德股价一度大跌17% 此前下调全年展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2555405590","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555405590?lang=zh_cn&edition=full","pubTime":"2025-07-29 19:44","pubTimestamp":1753789440,"startTime":"0","endTime":"0","summary":"诺和诺德股价一度大跌17%,创去年12月20日以来最大跌幅,此前这家丹麦制药公司下调了全年销售和经营利润预期。\n 其他欧洲肥胖症药物开发商股价下跌:Zealand Pharma下跌5.6%,Gubra下跌5.6%。\n 礼来股价在美国盘前交易中一度下跌3.6%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:刘明亮","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-07-29/doc-inficwtr4617115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","BK4585","LU1093756325.SGD","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVO","BK4532","LU1093756168.USD","BK4007","LU0154236417.USD"],"gpt_icon":0},{"id":"2555022056","title":"Mike Doustdar被任命为诺和诺德CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2555022056","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555022056?lang=zh_cn&edition=full","pubTime":"2025-07-29 19:41","pubTimestamp":1753789285,"startTime":"0","endTime":"0","summary":"格隆汇7月29日|据市场消息,Mike Doustdar被任命为诺和诺德(NVO.US)总裁兼首席执行官。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291942019725554f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291942019725554f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4599","BK4585","NVO","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","BK4007"],"gpt_icon":0},{"id":"2555214055","title":"美股前瞻 | 三大股指期货齐涨,诺和诺德下调2025年展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2555214055","media":"智通财经","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555214055?lang=zh_cn&edition=full","pubTime":"2025-07-29 19:40","pubTimestamp":1753789254,"startTime":"0","endTime":"0","summary":"目前,国会正在大力规范该行业。Oppenheimer上调标普500年终目标至7100点。个股消息诺和诺德下调2025年销售增长及利润预期。诺和诺德周二警告称,全年销售额和营业利润增长将低于此前预期,这是该公司第二次下调2025年的预期。过去一年,诺和的股价大幅下跌。以当地货币计算,诺和诺德目前预计2025年销售额将增长8%-14%,低于此前13%-21%的预期。截至发稿,诺和诺德盘前股价跌超20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4599","BK4585","LU1093756325.SGD","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVO","BK4532","LU1093756168.USD","BK4007","LU0154236417.USD"],"gpt_icon":1},{"id":"2555053292","title":"诺和诺德:前六个月,诺和诺德的销售额增长了18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555053292","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555053292?lang=zh_cn&edition=full","pubTime":"2025-07-29 19:23","pubTimestamp":1753788182,"startTime":"0","endTime":"0","summary":"诺和诺德表示,2025年前六个月,诺和诺德的销售额增长了18%,营业利润增长了29%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/29192352061034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1093756325.SGD","NVO","IE00BKVL7J92.USD","LU1093756168.USD","BK4588","BK4532","IE00BZ1G4Q59.USD","BK4007","LU0154236417.USD","BK4599","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":-0.1923},{"period":"1month","weight":-0.2127},{"period":"3month","weight":-0.1883},{"period":"6month","weight":-0.3679},{"period":"1year","weight":-0.5788},{"period":"ytd","weight":-0.3729}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.1456},{"period":"6month","weight":0.0499},{"period":"1year","weight":0.1661},{"period":"ytd","weight":0.0839}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球医疗保健公司,也是糖尿病和肥胖症护理领域的全球领导者。该公司拥有广泛的糖尿病和肥胖症护理以及罕见疾病产品组合,包括用于治疗糖尿病和肥胖症的胰高血糖素样肽-1(GLP-1)受体激动剂、现代胰岛素和人胰岛素。","yearOnYearQuotes":[{"month":1,"riseRate":0.522727,"avgChangeRate":0.119015},{"month":2,"riseRate":0.613636,"avgChangeRate":0.028062},{"month":3,"riseRate":0.454545,"avgChangeRate":0.006986},{"month":4,"riseRate":0.613636,"avgChangeRate":0.01505},{"month":5,"riseRate":0.555556,"avgChangeRate":0.018382},{"month":6,"riseRate":0.688889,"avgChangeRate":0.026171},{"month":7,"riseRate":0.488889,"avgChangeRate":0.00052},{"month":8,"riseRate":0.522727,"avgChangeRate":0.001751},{"month":9,"riseRate":0.568182,"avgChangeRate":-0.002657},{"month":10,"riseRate":0.5,"avgChangeRate":-0.002241},{"month":11,"riseRate":0.613636,"avgChangeRate":0.027229},{"month":12,"riseRate":0.727273,"avgChangeRate":0.04916}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}